2012 Drug Resistance Gordon Research Conference

2012年耐药戈登研究会议

• 批准号: 8317862
• 负责人: Margaret A. Riley
• 金额: $ 0.6万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-06-01 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8317862
• 关键词: Address; Anti-Infective Agents; Area; Basic Science; Cancerous; Cells; Collaborations; Communities; Development; Disabled Persons; Disease; Disease Resistance; Drug Delivery Systems; Drug Design; Drug resistance; Drug resistance pathway; Evolution; Goals; Health; International; Longevity; Malignant Neoplasms; Minority; Parasites; Parasitic Diseases; Participant; Patients; Pharmaceutical Preparations; Postdoctoral Fellow; Request for Applications; Research; Research Personnel; Resistance; Resources; Structure; Students; Time; Viral; Woman; Work; college; design; drug development; drug discovery; insight; meetings; member; microbial disease; mortality; neglect; novel; novel strategies; parity; pathogen; posters; programs; symposium; viral resistance

DESCRIPTION (provided by applicant): This application requests partial support for a new Gordon Research Conference on Drug Resistance to be held July 29-August 3, 2012 at Stonehill College in Easton, MA. The broad and long-term goal of this conference is to bring together, for the first time, the world's leading researchers in this rapidly expanding field to foter cross-disciplinary discussions and collaborations, so as to enhance our understanding of drug resistance evolution. This goal focuses on the development of new insights on drug resistance pathways and mechanisms that can be incorporated into the design of novel drugs. The specific aims of this meeting will be to convene over 40 leading experts that cover critical areas of drug resistance, with a total of 150 participants for a five-day conference in a relatively isolated setting. The program will be structured into nine sessions covering the drug resistance challenge, resistance in microbial diseases, resistance in viruses, resistance in fungal and parasitic diseases, resistance in cancer, the evolution of resistance, the targeting of anti-infective targets to reduce resistance, novel drug targets, drug discovery, and multi-disciplinary approaches to tackling drug resistance. In addition, afternoon poster sessions will permit all participants to contribute to these topics. Every effort will be made to encourage participation by postgraduate students and postdocs, to have parity in the numbers of women, and to include minorities and persons with disabilities. The significance of this application is that this Gordon Research Conference will provide the first-ever forum for bringing together and synergizing members of the international research community working on the drug resistance challenge. The health relatedness of this application is that the discussions generated will help define the important questions related to both basic science and those required for the development of novel strategies for drug design and development; definitions desperately required so as to reduce the very high levels of mortality associated with drug resistance. PUBLIC HEALTH RELEVANCE: The occurrence of drug resistance negatively impacts the lives of millions of patients by limiting the longevity of many of our most potent drugs. In most cases, drug resistance is investigated as a disease specific endeavor the results of which are that clinicians and researchers are often unaware of the progress, resources, and parallels in other diseases. The discussions of current research at this Gordon Research Conference will define important questions that need to be addressed for the development of new drug design and development strategies for the control of resistant pathogens and cancerous cells by leveraging a cross disciplinary and cross disease perspective.

描述（由申请人提供）：本申请要求部分支持将于2012年7月29日至8月3日在马萨诸塞州伊斯顿的斯通希尔学院举行的新的戈登耐药性研究会议。本次会议的广泛和长期目标是首次将这一迅速发展领域的世界领先研究人员聚集在一起，促进跨学科讨论和合作，从而加强我们对耐药性演变的理解。这一目标的重点是对耐药途径和机制的新见解的发展，这些见解可以纳入新药的设计中。这次会议的具体目标将是召集40多名涉及耐药性关键领域的主要专家，共有150名与会者在一个相对孤立的环境中参加为期五天的会议。该计划将分为九个会议，涵盖耐药性挑战、微生物疾病的耐药性、病毒的耐药性、真菌和寄生虫疾病的耐药性、癌症的耐药性、耐药性的演变、靶向抗感染靶点以减少耐药性、新型药物靶点、药物发现以及解决耐药性的多学科方法。此外，下午的海报会议将允许所有参与者对这些主题做出贡献。将尽一切努力鼓励……的参与